Novo Nordisk said on Friday the U.S. Food and Drug Administration has granted accelerated approval for its weight-loss drug ...

Novo Nordisk’s obesity drug Wegovy was cleared by U.S. regulators to treat an increasingly common liver disease, MASH.

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved an additional indication for Wegovy® ...

Novo Nordisk (NVO) stock in focus as the company wins FDA accelerated nod for weight loss therapy Wegovy against the liver ...

Yankees can mash, but playoffs will expose run prevention weakness again originally appeared on Athlon Sports. The Yankees ...

I am reversing my rating on Akero Therapeutics stock from Buy to Sell due to valuation concerns and a long-ish wait for ...

HistoIndex’s AI-based FibroSIGHT Plus’s launch coincides with the MASH space’s pharma market potential swelling across the ...

Amateur fossil hunter Ross Dullard, who found the partial skull, says he will celebrate with a whale-themed party, marking ...

Going up against these giants is no small challenge, but Viking is, so far, holding its own. And if it can play its cards ...

Fowling, the mash-up of football and bowling, is coming to Minneapolis at new venue originally appeared on Bring Me The News.

MASLD has become the most common chronic liver disease worldwide. The authors review the features of the disease as well as ...

A rom-com thriller, two girls of different races finding their futures, and Nick Carraway writes “Gatsby.” Fun reads for the lazy days of August. “Matchmaking for Psychopaths”: by Tasha Coryell ...